SEP 23, 2021
Academy Leads Charge to End Step Therapy in Medicare Advantage Plans
CMS’ new administration signaled it is open to working on solutions to address step therapy for Part-B drugs in Medicare Advantage plans, which would help reduce patient and physician burdens.